Aβ1–42 aggregation inhibitor 1
CAT:
804-HY-150003-02
Size:
25 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

Aβ1–42 aggregation inhibitor 1
- CAS Number: 2439107-75-0
- UNSPSC Description: Aβ1-42 aggregation inhibitor 1 inhibits AChE (acetylcholinesterase) and BuChE (butyrylcholinesterase) with the IC50 value of 2.64 μM and 1.29 μM, respectively. Aβ1-42 aggregation inhibitor 1 inhibits self-mediated Aβ1-42 aggregation by 51.29% at a concentration of 25 μM. Aβ1-42 aggregation inhibitor 1 has the potential for the research of anti-Alzheimer's disease[1].
- Target Antigen: Amyloid-β; Cholinesterase (ChE)
- Type: Reference compound
- Related Pathways: Neuronal Signaling
- Applications: Neuroscience-Neurodegeneration
- Field of Research: Neurological Disease
- Assay Protocol: https://www.medchemexpress.com/aβ1-42-aggregation-inhibitor-1.html
- Solubility: DMSO : 100 mg/mL (ultrasonic)
- Smiles: CCN1C2=CC=C(/C=C/C3=CC=C(C=C3)NC(NCCN4CCCC4)=S)C=C2C5=CC=CC=C51
- Molecular Weight: 468.66
- References & Citations: [1]Dushyant V Patel, et al. Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents. Bioorg Chem. 2020 Aug;101:103977.
- Shipping Conditions: Room Temperature
- Clinical Information: No Development Reported